Pure Global
NCT05173233

Confirmatory Clinical Study of Treating Tricuspid Regurgitation With K-Clip TM Transcatheter Annuloplasty System

Shanghai Huihe Medical Technology Co., Ltd·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Tricuspid Regurgitation
Drug/Device/Intervention
Transcatheter Annuloplasty
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Shanghai Huihe Medical Technology Co., Ltd
Timeline & enrollment
Phase
N/A
Start date
May 15, 2022
End date
May 15, 2027
Enrollment
67 participants
Primary outcome

All-cause mortality,Change of Tricuspid Regurgitation Grade

Summary

The present clinical trial is performed to evaluate the effectiveness and safety of
 transcatheter tricuspid annuloplasty system manufactured by Shanghai Huihe Healthcare
 technology Co.,Ltd. for the treatment of subjects with severe or worse tricuspid
 regurgitation.

ICD-10 classifications
Tricuspid stenosisTricuspid stenosis with insufficiencyNonrheumatic tricuspid (valve) stenosisTricuspid insufficiencyNonrheumatic tricuspid (valve) stenosis with insufficiency
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05173233
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05173233 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai Huihe Medical Technology Co., Ltd and is currently Not yet recruiting. The study focuses on Tricuspid Regurgitation. Target enrollment is 67 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.